WCN26-6575 CHANGE IN SOLUBLE BIOMARKER LEVELS IN PATIENTS WITH IgA NEPHROPATHY: AN ANALYSIS OF THE PHASE 2 TRIAL OF RAVULIZUMAB (SANCTUARY)

Read full text Summarise with VIRAT
Authors: Jonathan Barratt, Tobin J. Cammett, Ellen E. Millman, Julio C. Luna, Kara Creamer Rice, Katherine G. Garlo, Andreas K. Kateifides, STEPHEN T. NOLAN, Cory Williams, Richard A. Lafayette, Youssef M.K. Farag
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Complement system in diseases Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104504–104504
Publication date
25 March 2026
Language
EN